CRISPR-carrying nanoparticles edit the genome
New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.
New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
Biological engineers identify genes that protect against protein linked to Parkinson’s disease.
MIT associate professor and member of the Broad Institute and McGovern Institute recognized for commitment to invention, collaboration, and mentorship.
Five recipients honored for their fundamental and complementary accomplishments related to CRISPR-Cas9.
Mark Bathe develops molecular packages for targeted delivery of drugs, vaccines, and gene-editing tools.
Red, green, and blue light can be used to control gene expression in engineered E. coli.
SDSCon 2017 gathers community and showcases research projects that apply data science to major systems and issues.
Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.
New system adapts tool known for gene editing; to be used in rapid, inexpensive disease diagnosis.
MIT professor and NAS report committee co-chair Richard Hynes gives insight into the report’s recommendations.
Charles Jennings of MIT’s McGovern Institute discusses the intellectual property dispute over the gene-editing technique.
CRISPR pioneer named to inaugural chair created by Patricia and James Poitras '63, founders of MIT’s Poitras Center for Affective Disorders Research.
MIT and Broad Institute scientist shares recognition with four other scientists for developing CRISPR gene-editing systems.
New technique offers precise manipulation of when and where genes are targeted.